Ranbaxy Case

Delhi Police have filed a charge sheet against Sukesh Chandrashekhar and Leena Paul for allegedly cheating the family of ex Fortis Healthcare and Ranbaxy Lab promoters Shivinder and Malvinder Singh of over Rs 200 crore.

The apex court on November 15, 2019 had held former Ranbaxy promoters guilty of contempt of court for violating its order asking them not to divest their shares in FHL.

Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.

A Delhi court on Thursday extended the judicial custody of former Ranbaxy owners Shivinder and Malvinder Singh for 14 days in connection with the Religare funds scam case.

A Delhi court today sent former Ranbaxy promoter Malvinder Singh and his brother Shivinder Singhto judicial custody in a Rs. 2,397 crore fraud case.

A Delhi court today extended the police custody of three people, including former Ranbaxy promoters Malvinder Singh and Shivinder Singh, on charges of allegedly misappropriating funds at Religare Finvest Limited to the tune of Rs 2,397 crore.

Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh, his older brother Malvinder Singh and three others have been sent to four-day police custody in a Rs 740-crore fraud case.

Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh and his older brother Malvinder Singh were arrested on Thursday in a Rs 740-crore fraud case.

Malvinder Singh and his brother Shivinder Singh, ex-promoters of pharmaceutical giant Ranbaxy, were raided today by the Enforcement Directorate in a Rs 740-crore fraud case. against the former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh.

The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...

The Supreme Court today asked former Fortis Healthcare promoters and estranged brothers Malvinder Singh and Shivinder Singh to inform it on how they plan to comply with a Rs 3,500 crore arbitration order passed against them by a Singapore tribunal. "You were the flag bearers of the pharmacare industry and it doesn't look good that you are appearing...

Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.

Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.

The verdict, handed down Friday in federal court in Boston, is the first time a jury has decided such a case since the US Supreme Court ruled last year that so-called "pay-for-delay" settlements may run afoul of antitrust laws.

US District Judge Peter Sheridan in Trenton, New Jersey, ruled that the plaintiffs, retailers and distribution companies that bought Lipitor directly from Pfizer, failed to plead their case with enough detail.

Delhi Police have filed a charge sheet against Sukesh Chandrashekhar and Leena Paul for allegedly cheating the family of ex Fortis Healthcare and Ranbaxy Lab promoters Shivinder and Malvinder Singh of over Rs 200 crore.

The apex court on November 15, 2019 had held former Ranbaxy promoters guilty of contempt of court for violating its order asking them not to divest their shares in FHL.

Ex-Ranbaxy promoters Malvinder Singh and his brother Shivinder Singh have been held guilty by the Supreme Court of contempt of court in a case filed by Japanese firm Daiichi Sankyo.

A Delhi court on Thursday extended the judicial custody of former Ranbaxy owners Shivinder and Malvinder Singh for 14 days in connection with the Religare funds scam case.

A Delhi court today sent former Ranbaxy promoter Malvinder Singh and his brother Shivinder Singhto judicial custody in a Rs. 2,397 crore fraud case.

A Delhi court today extended the police custody of three people, including former Ranbaxy promoters Malvinder Singh and Shivinder Singh, on charges of allegedly misappropriating funds at Religare Finvest Limited to the tune of Rs 2,397 crore.

Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh, his older brother Malvinder Singh and three others have been sent to four-day police custody in a Rs 740-crore fraud case.

Pharmaceutical giant Ranbaxy's ex-promoters Shivinder Singh and his older brother Malvinder Singh were arrested on Thursday in a Rs 740-crore fraud case.

Malvinder Singh and his brother Shivinder Singh, ex-promoters of pharmaceutical giant Ranbaxy, were raided today by the Enforcement Directorate in a Rs 740-crore fraud case. against the former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh.

The former promoters of pharmaceutical company Ranbaxy, Malvinder Mohan Singh and his brother Shivinder Mohan Singh, were told by the Supreme Court today that they could go to jail for disobeying orders to pay dues to Japanese firm Daiichi Sankyo. "We will go into the issue - why you violated our orders. We will send you to jail. We have given you ...

The Supreme Court today asked former Fortis Healthcare promoters and estranged brothers Malvinder Singh and Shivinder Singh to inform it on how they plan to comply with a Rs 3,500 crore arbitration order passed against them by a Singapore tribunal. "You were the flag bearers of the pharmacare industry and it doesn't look good that you are appearing...

Billionaire Shivinder Mohan Singh, co-founder of hospital chain Fortis Healthcare and former Ranbaxy promoter, has filed a case against his elder brother Malvinder Mohan Singh alleging "oppression and mismanagement" at their joint businesses - RHC Holding, Religare and Fortis.

Singh brothers lost the case in Singapore arbitration court that ordered them to pay Rs 3,500 crore to Daiichi Sankyo.

The verdict, handed down Friday in federal court in Boston, is the first time a jury has decided such a case since the US Supreme Court ruled last year that so-called "pay-for-delay" settlements may run afoul of antitrust laws.

US District Judge Peter Sheridan in Trenton, New Jersey, ruled that the plaintiffs, retailers and distribution companies that bought Lipitor directly from Pfizer, failed to plead their case with enough detail.